GT Biopharma Inc. (GTBP)
undefined
undefined%
At close: undefined
2.75
-2.10%
After-hours Dec 13, 2024, 03:59 PM EST

GT Biopharma Inc. Forcast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for GTBP stock have an median target of 11, with a low estimate of 11 and a high estimate of 11. The median target predicts an increase of 291.46% from the current stock price of 2.81.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change 291.46% 291.46% 291.46% 291.46%

AI Analyst Report

According to 1 stock analyst, the rating for GT Biopharma Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Dec 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
13.00M
from 0
Increased by -%
Revenue Next Year
13.50M
from 13.00M
Increased by 3.8%
EPS This Year
-10.8
from -5.64
Increased by -91.5%
EPS Next Year
-19.2
from -10.8
Increased by -77.8%